CINXE.COM

<!DOCTYPE html> <html lang="en"> <head> <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1" /> <meta charset="utf-8" /><script type="text/html" id="sf-tracking-consent-manager"> <style> /*Consent Form*/ #tracking-consent-dialog { padding: 15px; position: fixed; bottom: 0; right: 5px; width: 337px; border: 3px solid #1e82e0; border-radius: 5px 5px 0px 0px; background: rgba(255, 255, 255, .95); font-size: 16px; z-index: 999; } #tracking-consent-dialog-accept { background-color: #1e82e0; color: #fff; font-size: 16px; font-weight: 500; float: right; } .consent-close { font-weight: bold; float: right; padding: 2px 7px; right: 6px; top: 3px; cursor: pointer; font-size: 11px; position: absolute; background-color: #1e82e0; color: #fff; z-index: 999; border-radius: 50%; } @media (max-width: 767px) { #tracking-consent-dialog { width: 100%; font-size: 14px; } } </style> <div id="tracking-consent-dialog"> <div class="consent-close" onclick="TrackingConsentManager.updateUserConsent(true)">X</div> Cookie Policy CII uses cookies to improve your website & conference experiences, including enhancing website navigation, personalized features & promotions, evaluating our services, and customizing content and ads based on your preferences as you browse or engage with us. By clicking "Continue" or continuing to use our site, you are agreeing to our and our partners use of cookies. See our <a href="https://www.cambridgeinnovationinstitute.com/Privacy-Policy/">Privacy Policy</a> for more information. <button type="button" onclick="TrackingConsentManager.updateUserConsent(true)" id="tracking-consent-dialog-accept" class="btn btn-default">Continue</button> </div> </script><script type="text/javascript" src="/WebResource.axd?d=DzHrpQl5URXarFHAtrmzFrNeeCwCLwHK2gvGZ95fW9WnidZLXrfDlGTuxUr3l463ttkzDVh9D8Bug9pu7NHdr_V4jKJPpR5aBflu4f8Ts5edKoXW2sH8LcSZSfqlYNJ5LpoUn5WBE_fdKcz0yNVMxY3w_4XLcip6ESbZeM3DDdUqeeNFFCEiKQKGKqR186oo0&t=637922505220000000"> </script> <script src="/ScriptResource.axd?d=okuX3IVIBwfJlfEQK32K3iZZtiInnD21Q3naS01thH9-fzUaksT1ZtMUjWfsR2IfFrdwuSgx30ngwb9MjfyLwf8qicr33ktg3mwcpW2o3dsDH8d3-t4otTq9qT-5mrFfzK1f5nCn185AY5nCZScdoqJ1WOdlA_-4T4B_v3AbufPsc2J5Jr9-kOiHGAB_hap-0&t=4e1c7b51" type="text/javascript"></script><script src="/ScriptResource.axd?d=EydukmxBmDstn7gSYzQESGX1Bc6SUabUViYB9LpdmFW6eZLmGFNo26FA-YqkH5f3QjtPWjAHxth32_ExmLGGY1zv6AdaQenYAqaM29qW1bTxx1r5T--aFytKsL9IQMjnWBhhM3Ox0iMnCMCJK5xrzQardvmrid9DGkma-HwbE57flKsxZSkIFbT-h8oEIp2m0&t=4e1c7b51" type="text/javascript"></script><link href="/ResourcePackages/Bootstrap/assets/dist/css/main.min.css" rel="stylesheet" type="text/css" /><link href="/css/global.css" rel="stylesheet" type="text/css" /><link href="/css/editor.css" rel="stylesheet" type="text/css" /> <link href="//fonts.googleapis.com/css?family=Roboto:500,400,700" rel="stylesheet" type="text/css"> <meta name="viewport" content="width=device-width, initial-scale=1, minimum-scale=1, maximum-scale=1, user-scalable=no" /> <meta property="og:image" content="/images/librariesprovider30/agenda/23/og/1800x940-poster-og.jpg" /><meta property="og:title" content="Poster Titles - PEGS Boston Summit" /><meta property="og:description" content="Poster Titles - PEGS Boston Summit" /><meta property="og:url" content="https://www.pegsummit.com/poster-titles" /><meta property="og:type" content="website" /><meta property="og:site_name" content="Pegs Summit" /><link href="/css/25/PEGS/style-pegs.css" media="all" rel="stylesheet" type="text/css" /><script type="text/javascript"> (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-KVWQZQJ'); </script><script type="text/javascript"> var link = document.createElement('link'); link.id = 'dynamic-favicon'; link.rel = 'shortcut icon'; link.href = '/images/librariesprovider30/template-images/25/favicon.png'; document.head.appendChild(link); </script><meta name="Generator" content="Sitefinity 14.2.7900.0 DX" /><link rel="canonical" href="https://www.pegsummit.com/poster-titles" /><script type="application/json" id="sf-insight-metadata"> {"contentMetadata":"{\"Id\":\"3947ca16-4cca-46e2-addf-4b4dd64ddb72\",\"ContentType\":\"Page\",\"Title\":\"Poster Titles\",\"CanonicalTitle\":\"Poster Titles\",\"CanonicalUrl\":\"https://www.pegsummit.com/poster-titles\",\"CreatedOn\":\"2019-02-04T18:23:43Z\",\"ModifiedOn\":\"2024-09-16T13:54:47Z\",\"SiteName\":\"Pegs Summit\",\"PageId\":\"3947ca16-4cca-46e2-addf-4b4dd64ddb72\"}","videosMetadata":"[]"} </script><script type="application/json" id="sf-insight-settings"> {"apiServerUrl":"https://api.insight.sitefinity.com/","apiKey":"62dc77b5-9fbc-74c6-8f79-d05463f0565e","applicationName":"CII_DEC","trackingCookieDomain":"","keepDecTrackingCookieOnTrackingConsentRejection":false,"slidingExpirationForTrackingCookie":false,"maxAgeForTrackingCookieInDays":365,"trackYouTubeVideos":true,"strategy":"Persist|False","docsHrefTestExpressions":[".*\\/docs\\/.+\\.{1}.+((\\?|\\\u0026)sfvrsn=.+){1}$",".+((\\?|\\\u0026)sf_dm_key=.+){1}$"]} </script><script type="text/javascript" src="/WebResource.axd?d=HtQyXelCu6mzSPcVcvK_BrDGcMZ2eaAwTGCTL_5l9xvo0iV9h2YYkvXanQ1uf0LidxbxWd8AzxNrppPmU7C9KnzDV98eKbg88D2zgKyY_GVq-IK4cwpq3ApmVVQHZ20G6_cSyVvbsc3d7cEOVVpoZalFAGFOo2fFcbG9u0riPX3ha1PNvfZCNU2C8dj5lXB2aevtM9BprQUEvuhENe--svD7i9F-8WutvDj5rAfLCkI1&t=637922505220000000"> </script><script src="https://cdn.insight.sitefinity.com/sdk/sitefinity-insight-client.min.3.1.7.js" async="async"> </script><link href="/Telerik.Web.UI.WebResource.axd?d=PMrIT5dOWaVYIcpFWUE4nCGcRFDqtHj8a0dT9N7jtPAWgyp5t5fff0pvXeFargWg3kuRljuyyjKW8grLvrafOr9X0kIEdj24q9AbiZ0prs7qITvLoGQxdqYfpMFPSD250&t=638482241021526486&compress=0&_TSM_CombinedScripts_=%3b%3bTelerik.Sitefinity.Resources%2c+Version%3d14.2.7900.0%2c+Culture%3dneutral%2c+PublicKeyToken%3db28c218413bdf563%3aen%3aec7772cc-ee32-478e-8437-4242283bb12f%3a7a90d6a" type="text/css" rel="stylesheet" /><title> Poster Titles - PEGS Boston Summit </title><meta name="description" content="Explore unique poster title presentations only available at PEGS protein and antibody engineering summit 2025. " /></head> <body><form method="post" action="./poster-titles" id="aspnetForm"> <div class="aspNetHidden"> <input type="hidden" name="ctl04_TSM" id="ctl04_TSM" value="" /> <input type="hidden" name="ctl05_TSSM" id="ctl05_TSSM" value="" /> <input type="hidden" name="__EVENTTARGET" id="__EVENTTARGET" value="" /> <input type="hidden" name="__EVENTARGUMENT" id="__EVENTARGUMENT" value="" /> <input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="lyxr9cU12U+0G8EtOkB7WYxzqeAIOJ6x7s8HhMH4AmP3mGZTxDsYT/jk8gOE8b0aKW6jw9QlUTyjQa32lT7md1p7dki7tnmQzZpHNGfWqqc=" /> </div> <script type="text/javascript"> //<![CDATA[ var theForm = document.forms['aspnetForm']; if (!theForm) { theForm = document.aspnetForm; } function __doPostBack(eventTarget, eventArgument) { if (!theForm.onsubmit || (theForm.onsubmit() != false)) { theForm.__EVENTTARGET.value = eventTarget; theForm.__EVENTARGUMENT.value = eventArgument; theForm.submit(); } } //]]> </script> <script src="/WebResource.axd?d=pynGkmcFUV13He1Qd6_TZA_YQJD9xSUnUi70uTXUUGkw9zf_LlVkiouvQJnBXeCn1svgT4yxk9LfN7iuqrWtXg2&t=638459680569584809" type="text/javascript"></script> <script type="text/javascript"> //<![CDATA[ var __cultureInfo = {"name":"en","numberFormat":{"CurrencyDecimalDigits":2,"CurrencyDecimalSeparator":".","IsReadOnly":true,"CurrencyGroupSizes":[3],"NumberGroupSizes":[3],"PercentGroupSizes":[3],"CurrencyGroupSeparator":",","CurrencySymbol":"$","NaNSymbol":"NaN","CurrencyNegativePattern":0,"NumberNegativePattern":1,"PercentPositivePattern":1,"PercentNegativePattern":1,"NegativeInfinitySymbol":"-∞","NegativeSign":"-","NumberDecimalDigits":2,"NumberDecimalSeparator":".","NumberGroupSeparator":",","CurrencyPositivePattern":0,"PositiveInfinitySymbol":"∞","PositiveSign":"+","PercentDecimalDigits":2,"PercentDecimalSeparator":".","PercentGroupSeparator":",","PercentSymbol":"%","PerMilleSymbol":"‰","NativeDigits":["0","1","2","3","4","5","6","7","8","9"],"DigitSubstitution":1},"dateTimeFormat":{"AMDesignator":"AM","Calendar":{"MinSupportedDateTime":"\/Date(-62135578800000)\/","MaxSupportedDateTime":"\/Date(253402300799999)\/","AlgorithmType":1,"CalendarType":1,"Eras":[1],"TwoDigitYearMax":2029,"IsReadOnly":true},"DateSeparator":"/","FirstDayOfWeek":0,"CalendarWeekRule":0,"FullDateTimePattern":"dddd, MMMM d, yyyy h:mm:ss tt","LongDatePattern":"dddd, MMMM d, yyyy","LongTimePattern":"h:mm:ss tt","MonthDayPattern":"MMMM d","PMDesignator":"PM","RFC1123Pattern":"ddd, dd MMM yyyy HH\u0027:\u0027mm\u0027:\u0027ss \u0027GMT\u0027","ShortDatePattern":"M/d/yyyy","ShortTimePattern":"h:mm tt","SortableDateTimePattern":"yyyy\u0027-\u0027MM\u0027-\u0027dd\u0027T\u0027HH\u0027:\u0027mm\u0027:\u0027ss","TimeSeparator":":","UniversalSortableDateTimePattern":"yyyy\u0027-\u0027MM\u0027-\u0027dd HH\u0027:\u0027mm\u0027:\u0027ss\u0027Z\u0027","YearMonthPattern":"MMMM yyyy","AbbreviatedDayNames":["Sun","Mon","Tue","Wed","Thu","Fri","Sat"],"ShortestDayNames":["Su","Mo","Tu","We","Th","Fr","Sa"],"DayNames":["Sunday","Monday","Tuesday","Wednesday","Thursday","Friday","Saturday"],"AbbreviatedMonthNames":["Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec",""],"MonthNames":["January","February","March","April","May","June","July","August","September","October","November","December",""],"IsReadOnly":true,"NativeCalendarName":"Gregorian Calendar","AbbreviatedMonthGenitiveNames":["Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec",""],"MonthGenitiveNames":["January","February","March","April","May","June","July","August","September","October","November","December",""]},"eras":[1,"A.D.",null,0]};//]]> </script> <script src="/Telerik.Web.UI.WebResource.axd?_TSM_HiddenField_=ctl04_TSM&compress=0&_TSM_CombinedScripts_=%3b%3bSystem.Web.Extensions%2c+Version%3d4.0.0.0%2c+Culture%3dneutral%2c+PublicKeyToken%3d31bf3856ad364e35%3aen%3a18f1b484-bbc5-4e2e-8ca4-477603537f34%3aea597d4b%3ab25378d2" type="text/javascript"></script> <script src="/ScriptResource.axd?d=oBrf1f-DLFBYf_XnAiQIerYbp6DB1yP-XX6e2f1MfVZVh0-b8UJuYKCCtCgeTZdgs__r0fZWEGLHIbAdafwt8M9e685ZdEjP_79w8Op8pqlhtK8RVD9yvuuHQYso7wAeipQsr1KNKlxF-82gFsHvkROGzjmcQ59FFLTFjwumrh-7zfhoHiIXFsqfCwU3VcIw0&t=4e1c7b51" type="text/javascript"></script> <script src="/Telerik.Web.UI.WebResource.axd?_TSM_HiddenField_=ctl04_TSM&compress=0&_TSM_CombinedScripts_=%3b%3bTelerik.Sitefinity.Resources%3aen%3aec7772cc-ee32-478e-8437-4242283bb12f%3ab162b7a1" type="text/javascript"></script> <script src="/Frontend-Assembly/Telerik.Sitefinity.Frontend/Mvc/Scripts/Bootstrap/js/bootstrap.min.js?package=Bootstrap&v=MTQuMi43OTAwLjA%3d" type="text/javascript"></script> <script src="/js/sgs/menu-wsub.js" type="text/javascript"></script> <div class="aspNetHidden"> <input type="hidden" name="__VIEWSTATEGENERATOR" id="__VIEWSTATEGENERATOR" value="9DA43042" /> </div><script type="text/javascript"> //<![CDATA[ Sys.WebForms.PageRequestManager._initialize('ctl00$ctl04', 'aspnetForm', [], [], [], 90, 'ctl00'); //]]> </script> <input type="hidden" name="ctl00$ctl04" id="ctl04" /> <script type="text/javascript"> //<![CDATA[ Sys.Application.setServerId("ctl04", "ctl00$ctl04"); Sys.Application._enableHistoryInScriptManager(); //]]> </script> <iframe id="__historyFrame" src="/ScriptResource.axd?d=IR6P3SKMs9JTTeEaIgRWrcZemQ7Hel_STKtN7lKcJZzavmbsKRBicvo3ofldpkvfDQJ86gYfZOQPT4XimBbVaQO_eDMbu2Afpps5fgghCxZt5x9t0OqMY4bZf_gZbTPe0" style="display:none;"> </iframe> <div> <div class="navbar navbar-default navbar-fixed-top"> <a class="navbar-brand large" href="/"></a> <div class="navbar-header"> <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-collapse"> </button> </div> <div class="collapse navbar-collapse" id="bs-example-navbar-collapse-1"> <ul class="nav navbar-nav large-nav" role="menu"> <li class="dropdown"> <a href="#" class="dropdown-toggle" role="button"> About </a> <ul role="menu" class="dropdown-menu"> <li class=""> <a href="/about" target="_self">About the Event</a> </li> <li class=""> <a href="/get-involved" target="_self"> Get Involved</a> </li> <li class=""> <a href="/event-features" target="_self">Event Features</a> </li> <li class=""> <a href="/media-gallery" target="_self">Media Gallery</a> </li> <li class=""> <a href="/testimonials" target="_self">Testimonials</a> </li> </ul> </li> <li class="dropdown"> <a href="#" class="dropdown-toggle" role="button"> Agenda </a> <ul role="menu" class="dropdown-menu"> <li class=""> <a href="/conference-streams" target="_self">Conference Programs</a> </li> <li class=""> <a href="/training-seminars" target="_self">Training Seminars</a> </li> <li class=""> <a href="/short-courses" target="_self">Short Courses</a> </li> <li class=""> <a href="/plenary-keynotes" target="_self">Plenary Keynote Sessions</a> </li> <li class=""> <a href="/speaker-biographies" target="_self">Speaker Biographies</a> </li> </ul> </li> <li class="dropdown"> <a href="#" class="dropdown-toggle" role="button"> Sponsor/Exhibitor </a> <ul role="menu" class="dropdown-menu"> <li class=""> <a href="/Sponsor" target="_self">Attendee Demographics + Event Features</a> </li> <li class=""> <a href="/sponsorship-opportunities" target="_self">Sponsorship Opportunities</a> </li> <li class=""> <a href="/sponsors" target="_self">Current Sponsors</a> </li> <li class=""> <a href="https://www.intheorious.com/chi/pub/pegs2025b_pub/" target="_blank">Current Exhibitors/Floorplan</a> </li> <li class=""> <a href="/exhibitor-prospectus-form" target="_self">Sponsor/Exhibitor Prospectus</a> </li> <li class=""> <a href="/exhibit-services-schedule" target="_self">Exhibit Services/Schedule</a> </li> <li class=""> <a href="https://www.healthtech.com/Lead-Gen/" target="_blank">Lead Generation Opportunities</a> </li> <li class=""> <a href="/faq" target="_self">FAQ</a> </li> <li class=""> <a href="https://spex-cii.com/" target="_blank">Sponsor & Exhibitor Portal</a> </li> <li class=""> <a href="/sponsor-exhibitor/best-of-show-awards" target="_self">Best of Show Awards</a> </li> <li class=""> <a href="/sponsor-exhibitor/product-launch" target="_self">Product Launch</a> </li> </ul> </li> <li class="dropdown"> <a href="#" class="dropdown-toggle" role="button"> Downloads </a> <ul role="menu" class="dropdown-menu"> <li class=""> <a href="/brochures" target="_self">Brochures</a> </li> <li class=""> <a href="/podcasts-and-interviews" target="_self">Podcasts</a> </li> </ul> </li> <li class=""><a href="/hotel-travel" target="_self">Travel</a></li> <li class="dropdown"> <a href="#" class="dropdown-toggle" role="button"> Posters </a> <ul role="menu" class="dropdown-menu"> <li class=""> <a href="/posters" target="_self">Present a Poster</a> </li> <li class="active"> <a href="/poster-titles" target="_self">Poster Titles</a> </li> <li class=""> <a href="/poster-winners" target="_self">Poster Winners</a> </li> </ul> </li> <li class="dropdown"> <a href="#" class="dropdown-toggle" role="button"> Press </a> <ul role="menu" class="dropdown-menu"> <li class=""> <a href="/in-the-news" target="_self">Newsroom</a> </li> <li class=""> <a href="/media-sponsors" target="_self">Media Partners</a> </li> <li class=""> <a href="http://www.healthtech.com/press.aspx" target="_blank">Press Pass</a> </li> </ul> </li> <li class="dropdown"> <a href="#" class="dropdown-toggle" role="button"> Register </a> <ul role="menu" class="dropdown-menu"> <li class=""> <a href="https://register.cambridgeinnovationinstitute.com/REG/PEG" target="_self">Individual Pricing</a> </li> <li class=""> <a href="https://register.cambridgeinnovationinstitute.com/reg/peg/group" target="_self">Group Pricing</a> </li> <li class=""> <a href="https://register.cambridgeinnovationinstitute.com/reg/PEG/ondemand" target="_self">On-Demand Pricing</a> </li> </ul> </li> </ul> </div> </div> </div> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-KVWQZQJ" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <div > <div class="sf-Long-text" > <div class="mobile-header hidden-sm hidden-md hidden-lg"><a href="/"><img class="imageResize" src="/images/librariesprovider30/template-images/25/header-mob.png?sfvrsn=d8cd2659_1" alt="PEGS Summit Boston" /></a> </div></div> </div> <div class="main-content"> <div id="cph1" class="container internal"> <div class="row"> <div class="row" data-sf-element="Row"> <div class="col-sm-9"> <div id="Contentplaceholder1_T846F6E09001_Col00" class="sf_colsIn pad-lr" data-sf-element="Column 1" data-placeholder-label="Column 1"> <div > <div class="sf-Long-text" ><h1 class="page-title">2025 POSTER PRESENTATIONS COMING IN APRIL</h1>Here is a reminder of the 2024 Poster PresentationsPOSTER SESSION A: Monday – Tuesday (morning)  A001: Selective IL-21 and IFN-a2 Immunocytokines Engineered Using the AlphaSeq Platform, Presented by Jeffrey A., A-Alpha BioA002: Design and Apply EGFR/c-Met/c-Met Trispecific Antibody for Cancer Therapy, Presented by Yue L., Ab Therapeutics, IncA003: Discovery of GPCR Antibody Agonists Using Functional Selection and Machine Learning, Presented by Lauren S., Abalone BioA004: Nanomolar VHH Binders of PD-L1 and Other Therapeutic Targets from the AbNano™ VHH Naive Library, Presented by Sam S., Abcore, a Fortis Life Sciences CompanyA005: A Native Multi-Dimensional Monitoring Workflow for At-Line Characterization of mAb Titer, Size, Charge, and Glycoforms Heterogeneities in Cell Culture Supernatant, Presented by Wayne H., Agilent Technologies, Inc.A006: XrossXeven: AI-Powered GPCR Protein Antigen De Novo Design, Presented by Patrick D., Ailux Biologics by XtalPiA007: Harnessing IL-18BP Modulation for Enhanced Cancer Immunotherapy: Antibody Engineering Strategies and Therapeutic Potential, Presented by Li Z., Alector, Inc.A008: 2D NMR for Higher Order Structure Assessment of Forced Degraded Monoclonal Antibodies, Presented by Sih Yao C., Amgen, Inc.A009: Bridging the Synthesis Gap: Automated Fast-Flow Peptide Synthesis (AFPS) Enables High-Fidelity Production of Difficult-to-Express Proteins, Presented by Kyuto T., Amide Technologies, Inc.A010: Quantification of the Antigen Density Activation Threshold for Targeted Immunotherapeutics, Presented by Lotta H., Antibody AnalyticsA011: Antibody Humanization with Predictive Design, Presented by Sridhar G., ATUMA012: Rapid Multiparametric Optimization of Antibody Using Yeast Autonomous Hypermutation, Presented by Jake H., Aureka Biotechnologies, Inc.A013: Novel Signal Peptide Screening-Based Platform for Optimization of Recombinant Protein Production, Presented by Tero-Pekka A., Avenue Biosciences, Inc.A014: Hypercell® Platform: High-Throughput Secretion-Based Single Cell Sorter and Its Application in Drug Discovery, Presented by Kyle N., Bioelectronica CorporationA015: Cloning and Expression of a Multi-Subunit Protein Using the MultiBacMam Expression System, Presented by Timothy G., BiogenA016: A Proven and Reliable Alpaca VHH Antibody Discovery Platform, Presented by Haoming Z., BiointronA017: TrailBlazer: A Rapid Modular Antibody Assembly Platform, Presented by Miao L., Bio-Rad LaboratoriesA018: Pioneer Platform: A Novel Biotherapeutic Antibody Discovery Platform, Presented by Francisco Y., Bio-Rad LaboratoriesA019: Preclinical Characterization of a Highly Differentiated Pan-Allele Anti-SIRPa Antibody BSI-082 that Targets the Myeloid Immune Checkpoint, Presented by Mingjiu C., Biosion USA, Inc.A020: Biotherapeutics for Animal Health, Presented by Ivan S., Boehringer Ingelheim Vetmedica GmbHA021: Ultra-Large Scale Biomanufacturing in the Fourth Industrial Wave, Presented by Chi-Ming Y., Boston Institute of BiotechnologyA022: Accelerating Functional Antibody Therapeutics Development with Bruker's Beacon Optofluidic System, Presented by Leqian L., Bruker ScientificA023: Relative Affinity Ranking of Recombinant Antigen-Specific Hits with Bruker’s Beacon Optofluidic System, Presented by Vincent P., Bruker ScientificA024: Three Case Studies of HPLC-MALS and ddPCR Analytical Platform Methods to Support Biopharmaceutical Drug Products, Presented by Felipe B., CambrexA025: Large-Scale Characterization of Drug Candidates Against Transmembrane Receptors Using HT-SPR, Presented by Josh E., Carterra, Inc.A026: MagDots: A Nanoparticle that Is Both Fluorescent and Magnetic for the Single Label Enrichment of Targeted Cells in Yeast Display Libraries, Presented by Mythreyi U., Core Quantum TechnologiesA027: Discovery of High-Affinity Anti-Glycan Antibodies Using Glycoengineered Bacterial Vesicles, Presented by Weiyao W., Cornell UniversityA028: Immuno-STATs for Targeted Depletion of B Cells in Autoimmune Diseases, Presented by Nitin K., Cue BiopharmaA029: myTXTL Cell-Free Expression of Antibodies and Antibody Fragments, Presented by Nathan G., Daicel Arbor BiosciencesA030: Epitope Mapping Case Studies by Deep Mutational Scanning, Presented by Tiphanie P., DeeptopeA031: Mammalian Display Technology Platform for Therapeutic Lead Antibody Engineering, Presented by Donghui M., DIMA BiotechnologyA032: Generative AI Based Affinity Engineering of TCRs for Potent Soluble T Cell Engagers, Presented by Ross R., EtcemblyA033: Streamlined Antibody Drug Conjugate Production: A Holistic Approach to ADC Manufacturing, Presented by Dragan M., Eurofins CDMO Alphora, Inc.A034: Advancing Therapeutics Targeting Inflammatory Cytokines with Functional Cell-Based Assays, Presented by Debatri C., Eurofins DiscoverXA035: High Throughput Approaches for In Silico Developability, Production and Characterization in Antibody Discovery, Presented by Catia P., FairJourney Biologics SAA036: Antibody Discovery and Characterization: A Multidimensional Approach for Next-Generation Therapeutics, Presented by Joao S., FairJourney Biologics SAA037: Small Molecule Interactions with Membrane Proteins Using Flow Induced Dispersion Analysis, Presented by Mark K., Fida BiosystemsA038: Mammalian Display for Antibody Discovery, Presented by Richard M., Fusion AntibodiesA039: Future Fields' EntoEngine™: Revolutionizing Recombinant Protein Production with Transgenic Drosophila, Presented by Ela D., Future FieldsA040: Artificial Intelligence Automates the Assignment of Biacore SPR and Octet BLI Kinetic Binding Profiles for a Faster Characterization of Lead Series, Presented by Eriberto N., Genedata AGA041: Fast and Efficient Evaluation of the Impact of IgG Fc N-Glycan Structure on Effector Functions, Presented by Camilla S., GenovisA042: The FORGE™ Engine Discovers Novel Tissue-Targeting Moieties for Delivery of Antisense Oligonucleotides to Muscle, Adipose and Brain, Presented by Maya L., GensaicA043: Treatment of Solid Tumors with Antibody Drug Conjugates Targeting Aberrant O-Glycoproteins, Presented by Nisha S., GO TherapeuticsA044: Antibody CDR Design by Ensembling Inverse Folding with Protein Language Models, Presented by Diego D., GSKA045: Addressing the Antibody Germline Bias and Its Effect on Language Models for Improved Antibody Design, Presented by Tobias O., GSKA046: Anti-Inflammatory Clearance of Aß by a Chimeric Gas6 Fusion Protein, Presented by Gyunam J., Illimis TherapeuticsA047: High-Sensitive Immunopeptidomics for Identification of (Neo)antigens and Development of High-Efficient Biotherapeutics, Presented by Elise P., ImmuneSpecA048: New Humanized Mouse as High-Performance Fully Human Antibody Generator with More Potent Anti-hTIGIT Antibody Identified, Presented by Yu Z., ImmunocanA049: Functional Evaluation of Immuno-Oncology Drug Candidates in Customized Bioassays, Presented by Sofie P., ImmunXperts, a Q2 Solutions CompanyA050: Development of Cross-Reactive Immunological Material (CRIM) Assay for ENPP1 Deficiency, Presented by Di C., Inozyme PharmaA051: High Throughput Development of High-Affinity Fabs and VHH Using Minimalistic Libraries, Presented by Andre T., Institute for Protein InnovationA052: Preclinical Safety Assessment for Specificity of Biotherapeutics Using the Membrane Proteome Array, Presented by Rachel F., Integral MolecularA053: CCR8 Antibody Drug Conjugates: Targeting Regulatory T Cells for Tumor Sensitization, Presented by Sharon W., Integral MolecularA054: Early Cell Lines Development for Production of Therapeutic Molecules, Presented by Carlos S., FairJourney Biologics SAA055: Predicting the Clinical Pharmacokinetics of Candidate Therapeutic Antibodies, Presented by Kaitlyn G., Jackson LaboratoryA056: Translational Humanized Models for Immunotherapy Drug Development, Presented by Mike K., Jackson LaboratoryA057: Revolutionizing Bispecific Antibody Manufacturing via Transposase-Mediated Insertions, Presented by Mohammad H., Johnson & Johnson Innovative MedicineA058: Increasing Therapeutic Antibody Production via Double Gene Expression Cassettes, Presented by Annabel J., Johnson & Johnson Innovative MedicineA059: GPCR VLPs and Nanodiscs for Drug Discovery, Presented by Jia C., KactusA060: Cell-Free Spectroscopy Techniques for Antibody/Antigen Production and Screening, Presented by Shakiba N., Lawrence Livermore National LaboratoryA061: Pandemic Preparedness with ALiCE® - Scalable Eukaryotic Cell-Free Protein Synthesis Enables Ultra-Rapid Threat Response, Presented by Malene L., LenioBio GmbHA062: Rapid Screening and Scaled Manufacture of Immunogenic Virus-Like Particles in a Tobacco BY-2 Cell Free Protein Synthesis System, Presented by James N., LenioBio GmbHA063: Next Generation Binding: Measuring Cell Avidity to Fully Characterize Cell-Cell Interactions and Understand Mechanism of Action for Cellular Therapies, Presented by Russell M., LUMICKSA064: 2MW3311: Combating Autoimmune Diseases by Depleting Pathogenic T Cells via Anti-CXCR6, Presented by Hsueh L., Mabwell TherapeuticsA065: PHAME - Therapeutic Antibodies Against Intractable Drug Targets, Presented by Konstantin H., Max Planck Institute for Medical ResearchA066: Automated Workflow for Rank-Ordering Variants by Affinity Within a Yeast Surface Display Library, Presented by Derek V., Metaphore Biotechnologies, Inc.A067: Enhancing Therapeutic Efficacy of Monoclonal Antibodies with Zinc Finger Nuclease-Mediated Knockout of the FUT8 Gene in CHOZN® Cell Lines, Presented by Amber P., MilliporeSigmaA068: CAR-T Cells Based on a TCR Mimic Nanobody Targeting HPV16 E6 for Treating Cervical Cancer, Presented by Zhijian D., National Institutes of Health, National Cancer InstituteA069: Direct Solubilization to Produce Active Neuropathy Target Esterase, an ER Membrane Associated Protein, for Functional and Structural Studies, Presented by Yi H., National Institutes of Health, National Heart, Lung, and Blood InstituteA070: Single Domain Antibodies as Potent and Selective Inhibitors of Carbonic Anhydrase IX, Presented by Majida E., National Research Council CanadaA071: Development of a ‘Switchable’ Yeast for Antibody Discovery, Presented by Gregory B., Neochromosome, Inc.A072: Automated Purification of Proteins from NEBExpress Cell-free E. coli Protein Synthesis Reactions Using NEBExpress Ni-NTA Magnetic Beads and a Magnetic Particle Processor, Presented by Jackson B., New England BiolabsA073: Systematic Structural Evaluation of Polycystin Variants by CryoEM, Presented by Orhi E., Northwestern UniversityA074: Numaswitch – The Revolution of Peptein Production, Presented by Roxann G., NUMAFERM GmbHA075: Two-Cell Assays for High-Throughput Screening of Membrane-Bound Protein Targets, Presented by Ronald R., Partillion BioscienceA076: HiBiT: A Tiny Tag to Assess MOA-Based CAR-T Cell Potency, Presented by Julia G., Promega CorporationA077: Development of a MoA-Based Bioassay Platform for Safe and Rapid Assessment of Virus Neutralization, Presented by Kai H., Promega CorporationA078: Development of Bioluminescent No-Wash Fc Gamma Receptor Binding Immunoassay to Guide the Development of Antibody Therapeutics, Presented by Alissa K., Promega CorporationA079: RaGene: AI-Powered Gene Optimization Platform Maximizes Yield and Enhances Protein Stability, Presented by Wafaa A., Proteinea, Inc.A080: Salipro® Nano-Membrane Particles for the Discovery and Characterization of Antibodies Against Challenging Membrane Protein Targets, Presented by Peter J., Salipro BiotechA081: Discovery of Novel Therapeutics Against GPCRs, Ion Channels and Transporters Using the Salipro Platform, Presented by Sara B., Salipro Biotech ABA082: Design and Screening of FcyRIIb Selective Fc Domains to Enhance PD-1 Agonism and Treat Autoimmunity, Presented by Samuel P., Seismic TherapeuticA083: Discovery and Characterization of FcγRIIb Selective Antibodies to Enhance PD-1 Agonism and Treat Autoimmunity, Presented by Ishan S., Seismic TherapeuticA084: Utilizing a Cancer-Specific Peptide to Deliver a Novel Immunotherapy for the Treatment of Cancer, Presented by Shelby K., SRI InternationalA085: T Cell Targeting with PD-1-Selective Immune Cell Engagers Based on GlycoConnect™ Technology Show Favorable Efficacy and Tolerability, Presented by Remon V., Synaffix, A Lonza CompanyA086: Antigens for Integral Membrane Protein Antibody Discovery, Presented by Olivia E., Takeda PharmaceuticalsA087: Potent Antibody Discovery Using Yeast Display and Human IgG Transgenic Mice, Presented by Leike L., Takeda PharmaceuticalsA088: Membrane Protein Chimeric and Truncated Cell Line Generation for Biologics Screening, Presented by Dongyun W., Takeda PharmaceuticalsA089: Antibody Labeling Reagents to Rapidly Screen for Binding, Internalization, and Degradation of Biologics and Antibody Drug Conjugates, Presented by Ryan H., Thermo Fisher ScientificA090: Optimizing Expression and Purification Workflows for Membrane Proteins, Presented by Matt M., Thermo Fisher ScientificA091: Synthetic Biology Solutions to Accelerate Antibody Development, Presented by Claudia C., Thermo Fisher Scientific GENEART GmbHA092: TRIV-509, a Dual-Specific Antibody Targeting KLK5 and KLK7 Proteases, Binds at the Active Site with High Affinity and Inhibits Proteolytic Activity, Presented by Brantley H., Triveni BioA093: Optimization of a Glucagon-Like Peptide 1 Receptor Antagonist Antibody for the Treatment of Hyperinsulinism, Presented by Lindsay D., Twist BioscienceA094: Discovery and Optimization of Novel Complement Component 5a Receptor 1 Antagonistic Antibodies, Presented by Crystal S., Twist BioscienceA095: Journey Towards Advancing Cancer Immunotherapy via HLA-G Pathway Modulation with Anti-HLA-G Antibody (UCB4594), Presented by Ruth M., UCBA096: Innovation in ADC Development: Unleashing the Potential of In Vivo Phage Display Selections and Rabbit Derived VL Single-Domain Antibodies to Develop Highly Specific and Potent ADC´s Against Novel Targets, Presented by Frederico AS., University of LisbonA097: Sequence-Developability Mapping of Affibody and Fibronectin Paratopes via Library-Scale Variant Characterization, Presented by Gregory N., University of MinnesotaA098: Learning the Rules of T Cell Receptor Cross-Reactivity with Yeast Display, Presented by Dan H., University of OxfordA099: Cationic Peptide Anchor-Mediated Binding to Tumor Extracellular Matrix Improves Intratumoral Retention of Agonist CD40 Antibody, Presented by Yuting P., University of Texas at AustinA100: Discovery of High Affinity Functional Antibodies Specific for CXCR5 and Other Multi-Pass Membrane Proteins, Presented by Leslie B., VaccinexA101: Novel Bispecific Antibodies Effectively Enhance Therapeutic Efficacy in Thyroid Eye Disease (TED) by Targeting the Molecular Pathway and Disrupting the Biological Crosstalk Associated with the Condition, Presented by Jing L., VelaVigoA102: Optimizing Bispecific Antibody Production: Strategies for Improved Purity and Yield, Presented by Sundee D., WuXi BiologicsA103: Exploring Digital Twin Technology in Improving Surgical Outcomes, Presented by Rakan A., Johns Hopkins University<div>A104: Isolation and Characterization of Promising Anti-PD-1 Antibodies to Treat Cancer, Presented by Frida RV., Unidad de Desarrollo e Investigación en Bioprocesos (UDIBI)</div>  POSTER SESSION B: Tuesday (afternoon) – Wednesday B001: Real-Time Kinetics on Cells and Further Analytical Tools to Avoid the Translational Gap, Presented by Vera M., 2bind GmbHB002: Defining the Biophysical Design Parameters for Logic-Gated CAR-T Systems, Presented by Alexander P., A2 Biotherapeutics, Inc.B003: Biophysical Methodologies for the QC of Abcam Rabbit Monoclonal Antibodies (RabMAb®) and Proteins, Presented by Deborah ML., AbcamB004: PSMA x CD3 T-Cell Engagers with Potent Cytotoxicity and Low Cytokine Release, Presented by Raffi T., AbCelleraB005: An AI-Assisted Selective CD16A-Targeting NK Cell Engager Showed Superior Anti-Tumor Activity In Vitro, Presented by Jessica J., Ailux Biologics by XtalPiB006: Efficient Production of VHHs Containing Non-Canonical Amino Acids by Corynex®, Presented by Yumi N., Ajinomoto Co., Inc.B007: Establishment of Human Rare Disease Organoid Models and Development of Microphysiological System, Presented by Jae Hee B., Asan Medical CenterB008: Generation of Sarconoids from Angiosarcoma Patients as a Systematic-Based Rational Approach to Treatment, Presented by Da Jung J., Asan Medical CenterB009: Predicting HCP Levels in Therapeutic Protein Products, Presented by Jared D., AstraZenecaB010: Leap-In Transposases® - A New Paradigm of Cell Line Development, Presented by Claes G., ATUMB011: Optimized Recombinant Antibody Production: A Comprehensive End-to-End Solution by GENEWIZ, Presented by Jung D., Azenta Life SciencesB012: Investigating Factors Impacting TLR7 Immunostimulatory ADC Pharmacokinetics and Pharmacodynamics, Presented by Samantha B., Binghamton University: The State University of New YorkB013: Implementing Design of Experiment (DOE) in ADA Optimization for Targeted Therapeutics, Presented by Matthew B., BioAgilytix LabsB014: Development of High Throughput Single-B Cell Antibody Discovery Platform, Presented by Huanyi Y., BiointronB015: Computationally Designed Multibodies: Binding Two Unrelated Targets with One, Symmetrical Standard Human IgG Antibody, Presented by Yael D., Biolojic DesignB016: Accurate Profiling of Full-Length Fv in Highly Homologous Antibody Libraries Using UMI-Tagged Short Reads, Presented by Yair F., Biolojic DesignB017: Rapid Generation of Bispecific Antibodies for High Throughput Screening with SpyLock Technology, Presented by Erika H., Bio-Rad LaboratoriesB018: Comprehensive Analysis and Characterization of Glycan Pairing in Therapeutic Antibodies and Fc-Containing Biotherapeutics, Presented by Maximilian M., Boehringer Ingelheim Pharma GmbH & Co. KGB019: Throughput Meets Flexibility: The Next Generation Multiplexing SPR for Efficient Therapeutic Protein Discovery and Development, Presented by Matthew P., Bruker ScientificB020: HT-SPR Evaluation of Fc Gamma Receptor Binding Using Carterra LSA-XT, Presented by Maria M., Carterra, Inc.B021: Digital Control of Expression for Rapid, High-Titer Production of Complex Products in CHO Cells, Presented by Chad H., Catalent BiologicsB022: Exploring the Dynamic Changes of Nucleic Acids to Evaluate the Effect of Protonated Nucleotides on Structure and Binding, Presented by Stefania E., Chemical Computing GroupB023: Immuno-STATs (ISTs): A Novel and Unique T-Cell Engager Platform for the Treatment of Immuno-Oncology and Autoimmune Diseases, Presented by Ahmet V., Cue BiopharmaB024: Antibody Analyses with Biacore™ System - Convenient, Sensitive, Versatile, Presented by Eric R., CytivaB025: Modulation of Antibodies' Fc Fragment Interaction with Fc Receptors by Deep Mutational Scanning, Presented by Fabien Q., DeeptopeB026: Comprehensive Cell-Based Assays for Characterization and Development of Agonistic Antibodies as Therapeutics for Cancer and Autoimmune Diseases, Presented by Gaurav A., Eurofins DiscoverXB027: FcRN Binding Assessment of IgG Fc Variants: A 360° View with Affinity, Kinetics and In Vitro Testing, Presented by Silvestre L., FairJourney Biologics SAB028: Applying Flow Induced Dispersion Analysis for In-Solution Binding Kinetics, Presented by Henrik J., Fida BiosystemsB029: Model Acetylcholinesterase-Fc Fusion Glycoprotein Biotechnology System for the Manufacture of an Organophosphorus Toxicant Bioscavenging Countermeasure, Presented by Tylee H., Food and Drug AdministrationB030: Development of a Chemically Defined Growth Medium Specifically Designed for CHO DG44 Cells, Presented by Ociel F., FUJIFILM Irvine ScientificB031: Advancing Antibody Therapeutics: Leveraging Biolayer Interferometry for Label-Free Camelid Nanobody Quantitation and Kinetics Screening, Presented by Vivienne L., Gator BioB032: NeoMab™: A Novel Platform for Fully Human Therapeutic Antibody Development, Presented by Jun W., GemPharmatechB033: Structure of the Wnt-Frizzled-LRP6 Initiation Complex Reveals the Basis for Coreceptor Discrimination, Presented by Sunhee H., GenentechB034: Leveraging Multiplexed MAPPs Data for In Silico and In Vitro Immunogenicity Risk Assessment, Presented by Prasad P., Generate BiomedicinesB035: Fully Automated TNFα Epitope Mapping with Benchtop Hydroxyl Radical Protein Footprinting Technology, Presented by Jiana D., GenNext Technologies, Inc.B036: Enzymatic Tools for Generation of Homogeneous Antibody Fragments – From High-Throughput Screening to Manufacturing Scale, Presented by Laurent R., GenovisB037: Integrated Solutions for Antibody Drug Development: A Comprehensive Approach with GenScript, Presented by Amanda G., GenScript USA, Inc.B038: Design and Engineering of Multi-Specific Antibody and Its Therapeutic Applications for AI Drug Discovery, Presented by Hengtai L., GenScript USA, Inc.B039: Automated High Throughput Purification Platform for Small Scale Expression in E.coli, Presented by Jane Z., GSKB040: Advanced High Throughput Particle Analysis: Characterizing Protein Therapeutic Stability from Developability Assessment to Release, Presented by Steven L., Halo LabsB041: Fc Engineering to Enable Subcutaneous Antibody Formulation and Beyond, Presented by Yasmin S., Illinois Institute of TechnologyB042: Early Unwanted Immunogenicity Risk Assessment of Biotherapeutics, Presented by Chloe A., ImmunXperts, a Q2 Solutions CompanyB043: Enhanced Plasmid Production: Achieving a 21-Fold Increase in Plasmids, Presented by Andrew M. and Sam E., INFORS HT & Thomson Instrument CompanyB044: DNA Nanotechnology Used to Rapidly Screen and Modulate T-Cell Engagement Using Hybrid DNA-Protein Analogs of Blinatumomab, Presented by Sabrine M., Institut National de la Recherche Scientifique - INRSB045: Bispecific and Trispecific GPRC5D Antibodies with Potent Cell-Killing Activity Against Multiple Myeloma, Presented by Ross C., Integral MolecularB046: Accelerating Antibody Discovery and Development to the Clinic with Proprietary Mammalian Display, Presented by Kothai P., Iontas Ltd.B047: A Novel, Translational Platform to Assess the Efficacy and Toxicity of Bispecific Antibodies, Presented by Joshua S., Jackson LaboratoryB048: Higher Order Structure, Stability, and Similarity Assessment of VHH Antibodies Using CD Spectroscopy, Presented by Ai Y., JASCO CorporationB049: Engineering Novel IgG Fc Glycosylation Sites for Bioconjugation, Presented by Zachary B., Johns Hopkins UniversityB050: Comparison of the Performance of Pharmalytes and AESLytes for Routine Capillary Isoelectric Focusing, Presented by Caleen D., Johnson & Johnson Innovative MedicineB051: ATF N-1/N Stage Perfusion Platform Process Development Using mAb Producing CHO Cell Culture, Presented by Kevin H., JOINN Biologics US, Inc.B052: Transforming Tumor Research: Engineering MHCs as Versatile Reagents, Presented by Manhee S., KactusB053: First Insights into Functionality of Cell-Free Produced Adalimumab in Comparison to Humira®, Presented by Ricarda F., LenioBio GmbHB054: Accelerating Drug Development with Flexible, Scalable, Single-Cell Functional Profiling, Presented by Simon M., Lightcast Discovery Ltd.B055: An Adaptor Platform Allows Selective CAR-T Cell Expansion by Cis-Targeting of Engineered Interleukin-2, Presented by Simone L., Ludwig Maximilians UniversityB056: Multiplexed Screening of 1000s of Brain Shuttle Designs In Vivo with Protein Barcoding to Engineer Blood-Brain Barrier Penetrating Therapeutics with Optimal Properties, Presented by Alex R., Manifold Biotechnologies, Inc.B057: Anti-Idiotypic Antibody as Booster Vaccine Against Respiratory Syncytial Virus, Presented by Shreya M., Merck & Co., Inc.B058: Scalable Transient Gene Expression in CHOZN® GS-/- Cells Using Thomson Optimum Growth® Flasks, Presented by Kelsey R., MilliporeSigmaB059: Integrating Cryo-EM into Therapeutic Discovery and Structural Toxicology, Presented by Nicole P., NanoImaging ServicesB060: Predicting Biologics Developability: A Combinatorial Approach with Thermal and Colloidal Stability Measurements for Improved Assessments, Presented by Rebecca H., NanoTemper Technologies, Inc.B061: Broadly Neutralizing Camel Nanobody J1B4 Against the S2 Subunit of SARS-CoV-2, Presented by Jessica H., National Institutes of Health, National Cancer InstituteB062: Novel Engineered T-Cells Targeting Glypican-2 Regress Antigen Low Neuroblastoma in Mice, Presented by Laura H., National Institutes of Health, National Cancer InstituteB063: Arsenal of Nanobodies Shows Broad-Spectrum Neutralization Against SARS-CoV-2 Variants of Concern In Vitro and In Vivo in Hamster Models, Presented by Martin R., National Research Council CanadaB064: NTxpress Platform Coupled with Hollow Fiber Bioreactors Can Be Leveraged to Produce Target Proteins, Presented by Robert J., Nature's ToolboxB065: Robust nanoCLAMP Protein Ligands for Affinity Chromatography, Presented by Richard S., Nectagen, Inc.B066: Rapid Method for Cell-Free Protein Synthesis (CFPS) from DNA or RNA Synthesized In Vitro, Presented by Paula M., New England BiolabsB067: Characterization of Therapeutic Antibodies Using Digital SPR, Presented by Michael P., Nicoya LifesciencesB068: Fully Human Heavy Chain Only Antibodies to BCMA Identified by NonaCarFx Platform, Presented by Jason N., Nona BiosciencesB069: Enhanced Brain Penetration and Neuronal Uptake Through Receptor-Mediated Transcytosis: Development of Fully Human Anti-TfR1 Heavy Chain Only Antibody Based Blood-Brain Barrier Shuttle Technology, Presented by Jiyong Z., Nona BiosciencesB070: Investigation of the Protein Sequence and Structural Determinants of Aggregation Resistance, Presented by Cydney M., Northwestern UniversityB071: Bioengineering of Site-Specific Antibody Labeling from Basic Research to Spatial Omics Platforms, Presented by Kai T., Oregon Health and Science UniversityB072: Co-Expression of MAGE-A3 and PD-L1 in Colon, Lung, and Bladder Cancers, Presented by Hailey G., Origene Technologies, Inc.B073: Developability Assessment for Nonspecificity and Polyspecificity in High-Throughput Bead-Based Assays in Microplates, Presented by Sebastian G., PAIA Biotech GmbHB074: A Novel Synthetic Receptor Changes CAR-T Cells into Superior Killers in Solid Tumors, Presented by Joe Z., Peter Maccallum Cancer CentreB075: High Titers of ncAA-Incorporated Therapeutic Protein Candidates Produced in Pseudomonas fluorescens, Presented by Nathaniel H., Primrose BioB076: Ankyrons – Target Binding Reagents Beyond Antibodies, Presented by Olivia W., ProImmune, Inc.B077: A Drug Development Platform for Protein Biologics that Integrates Production, Developability Assessment, Kinetic Profiling and High Resolution Cryo-EM and X-Ray Structural Determination, Presented by Joanna D., Proteros Biostructures GmbHB078: Multiplex Measurement of Tumor Biomarkers Associated with Colorectal Adenocarcinoma Using Novel Sample Types, Presented by James R., R&D Systems, Inc., a Bio-Techne brandB079: Structural Characterization of RNA and Detection of RNA-Ligand Binding Using Microfluidic Modulation Spectroscopy (MMS), Presented by Valerie C., RedShift BioAnalytics, Inc.B080: Development of a New Arrhenius Kinetics-Based Modeling Tool for Fast, Accurate and Robust Prediction of Long-Term Stability of Therapeutic Antibodies, Presented by Jiewei W., Regeneron PharmaceuticalsB081: Gene Therapy Applications on LabChip GX II Touch: From pDNA QC to mRNA Characterization, Presented by James W., RevvityB082: Sequence Variant Analysis to Support Process Development, Presented by Steven L., Samsung BiologicsB083: Accelerating the Discovery of a Pan-IgG Protease Using the IMPACT Platform, Presented by Soumya B., Seismic TherapeuticB084: Characterization of PD-1 Agonist Moieties of a Dual Cell Bidirectional Antibody to Treat Autoimmune Diseases, Presented by Rasika H., Seismic TherapeuticB085: Development of CAR-NK Cell Targeting Cancer-Associated Fibroblasts for Pancreatic Cancer Treatment, Presented by Jisu H., Seoul National UniversityB086: Fine-Tuning of Chimeric Antigen Receptor in Live Cells by Fluorescence Resonance Energy Transfer (FRET)-Based Biosensor, Presented by Hae Nim L., Seoul National UniversityB087: IL-21 On/Off Switch Loaded CAR-T Enhance Antitumor Effects by Epigenetic and Transcriptional Regulation, Presented by Hyungseok S., Seoul National UniversityB088: PSB123, an Anti-TIGIT –IL2 Fusion Protein Synergistically Activates Anti-Tumor Immune Responses Without Significant Toxicity, Presented by Wei Y., Sound BiologicsB089: Molecular Guidance Systems (MGSs) as Versatile Vehicles for Targeted Delivery of Oligonucleotides to Non-Hepatic Tissues, Presented by Michael M., SRI InternationalB090: TA Instruments RS-DSC: A Breakthrough in Thermal Stability Analysis, Presented by Christine N., TA InstrumentsB091: Thermostable Raman Interaction Profiling (TRIP), Presented by Narangerel A., Texas A&M UniversityB092: Molecular Recognition in the Interleukin-1 System, Presented by Glorise TM., Texas A&M UniversityB093: Invitrogen™ Vivofectamine™ LNP Solutions for RNA Delivery from Mouse to NHP, Presented by Henry C., Thermo Fisher ScientificB094: Optimizing Transient Protein Expression with Custom Media, Presented by Jason E., Thermo Fisher ScientificB095: A Novel 5L Shake Flask Suitable for Transient Protein Expression in the ExpiCHO, Expi293 and ExpiSF Production Systems, Presented by Sam W., Thermo Fisher ScientificB096: Antibody Discovery Identifies Regulatory Mechanisms of Protein Arginine Deiminase 4, Presented by Sophie K., University of California, San FranciscoB097: An Approach to Understand Nanobody Stability Enabling Large Scale Discovery, Presented by Yue W., University of California, San FranciscoB098: Solid Tumor Targeting by Cytotoxic T-Cells with a-T-Cell Receptor Nanobody Chemically Self-Assembled Nanorings (CSANs), Presented by Debasmita P., University of MinnesotaB099: Structure-Based Design of a Soluble Human Cytomegalovirus Glycoprotein B Antigen Stabilized in a Prefusion-Like Conformation, Presented by Madeline S., University of Texas at AustinB100: NanoLogix: An Open-Source Pipeline to Turbocharge Nanobody Discovery with High-Throughput Sequencing, Presented by Kathleen Z., Walter and Eliza Hall Institute of Medical ResearchB101: Rapid Antibody Lead Identification from Various Species Through Single B Cell Screening (VAST-B), Presented by Siwei N., WuXi BiologicsB102: Complementary Light Scattering Solutions for Protein Characterization, Presented by Michelle C., Wyatt TechnologyB103: Strategies to Sustain Bioprocess Development and Manufacturing, Presented by Hassan S., Lucensia Biosciences LLCB104: High Throughput Epitope Mapping and Screening in Live Cells, Presented by Dan B., Immuto Scientific  POSTER SESSION C: Thursday C001: ML-Guided Antibody Discovery and Optimization Using AlphaSeq and AlphaBind, Presented by Miranda L., A-Alpha BioC002: ABBV-400, a c-Met ADC: In Vitro Immunosafety Data Analysis, Presented by Susanne S., AbbVieC003: IgDesign: Antibody Inverse Folding with In Vitro Validation, Presented by Amir S., Absci CorporationC004: Comparing Potential Bispecific Formats of Trastuzumab and a Humanized OKT3, Presented by Catherine B., Absolute AntibodyC005: SARS-CoV-2 Neutralizing Antibodies Discovered in Serum Across Three Individuals Following Vaccination and Infection Show Diverse Epitopes Across Virus Spike Protein, Presented by Natalie C., Abterra BiosciencesC006: Development of High Throughput Screening Tools for the Purification of Bispecifics, Presented by Robert H., AbzenaC007: Analysis of NIST mAb Reference Material by Parallel SDS-Capillary Electrophoresis, Presented by Kyle L., Agilent Technologies, Inc.C008: XtalFold: An Antibody-Antigen/Protein-Protein Complex Structure Prediction Algorithm with Unprecedented Accuracy to Accelerate Therapeutics Development, Presented by Kyle K., Ailux Biologics by XtalPiC009: AJICAP® Technology Expanding Therapeutic Windows of ADCs and Accelerating Development of Novel Antibody-Based Conjugates, Presented by Takumi H., Ajinomoto Co., Inc.C010: Alternative CHO Harvest Process Development Using Acid Precipitation to Enable Process Scale-Up, Presented by Poorvaja G., Alexion AstraZeneca Rare DiseasesC011: Real-Time Kinetic Data in the Successful Development of an Inhibition of Proliferation Potency Bioassay, Presented by Lauren G., Antibody AnalyticsC012: Degradation Comparisons of Monoclonal Antibodies and Their Conjugated Forms, Presented by Dominique WD., AstraZenecaC013: Automating the CE-SDS, CE-N Glycan and cIEF Workflows for Downstream Analysis on the BioPhase 8800 System, Presented by John F., Beckman Coulter Life SciencesC014: Simple and High-Throughput Analytics for Proteins and Cells in Bioprocessing, Presented by Chip S., Beckman Coulter Life SciencesC015: Identification of a Novel Trop2-Targeting Immune Stimulating Antibody Conjugate (ISAC) with Efficacy in a Model of Pancreatic Cancer, Presented by Mohan M., Binghamton University: The State University of New YorkC016: Optimization and Evaluation of Legumain-Cleavable Topoisomerase-1 Inhibitor ADCs in a Pancreatic Cancer Model, Presented by Victor O., Binghamton University: The State University of New YorkC017: Generation of a Fully Human Antibody Library and Novel Linker/Payload to Facilitate Development of Antibody-Drug Conjugates and Other Antibody-Based Therapeutics, Presented by Luis H., Biocytogen PharmaceuticalsC018: Uncovering Factors Influencing Mannose Receptor Dependent Binding to Monoclonal Antibodies, Presented by Julia B., Boehringer Ingelheim Pharma GmbH & Co. KGC019: High-Throughput Automated Microfluidic Method to Identify Mispairing During Bispecific Antibody Production, Presented by Jenna R., Brown UniversityC020: Apolipoprotein E: Purification, Characterization, and Lipid Nanoparticle Uptake Enhancement, Presented by Alfredo G., Cayman Chemical CompanyC021: Tumbler: A Highly Customizable Antibody Optimization Suite, Presented by Michali I., Charles River LaboratoriesC022: Structure-Based Charge Calculations for Predicting Properties and Profiling Antibody Therapeutics, Presented by Alain A., Chemical Computing GroupC023: A Novel uPAR-Directed Antibody-Drug-Conjugate Eliciting Tumor Regression and Immunomodulation in Preclinical Models of Pancreatic Cancer, Presented by Virginia M., Copenhagen University HospitalC024: A Decoy ACE2 Shows Significant Efficacy Against SARS-CoV-2 Omicron Variants and Related Viruses: A Computational-Experimental Approach, Presented by Shahidul I., Delaware State UniversityC025: Development of a PhyTip-Based On-Resin Conjugation Workflow for OTV Biotherapeutics, Presented by Joanne C., Denali TherapeuticsC026: Fusion Protein Targeting PD-L1 and Neutralizing Gas6: A Potential Game Changer to Overcome the Glass Ceiling of Efficacy in Cancer Immunotherapy, Presented by Hui Chieh Y., Development Center for BiotechnologyC027: Discovery and Characterization of Biased Agonist and Antagonist Anti-hCCR5 Antibodies Using 3rd Generation ebBRET Biosensors, Presented by Guilhem D., Domain TherapeuticsC028: An Analysis of the Human Immunoglobulin Paired Repertoire Using Single Cell 10X and Overlap Extension RT-PCR Techniques, Presented by Monica W., Dotmatics, Inc.C029: Automated Spectrum Annotation and Structure Disambiguation of Released N-Linked Glycans, Presented by Gary W., Dotmatics, Inc.C030: Drug-to-Antibody Ratio of Maleimide-Based ADCs Greatly Impacts Fc Receptor Binding and Fc-Mediated Effector Activity, Presented by Danielle F., Eisai, Inc.C031: Engineering EVOLVE-106: A B7-H4-Targeting T Cell Engager with Integrated CD2 Co-Stimulation, Presented by Sonali D., EvolveImmune TherapeuticsC032: Automated Peptide Mapping and Intact Mass Analysis Data Processing Workflows for Streamlined MS-Based Characterization of AAV Capsids, Presented by Catherine E., Genedata AGC033: Accelerating Biopharmaceutical and Vaccine Research, Discovery, and Development with Genedata, Presented by Jana H., Genedata AGC034: High-Throughput Generation, Design, Production, and Evaluation of Bispecific Antibodies, Presented by Christian T., Genedata AGC035: A Cell Penetrating Cystine-Knot Peptide for Cargo Delivery, Presented by Yanjie L., GenentechC036: FORGE™-ML: A Diffusion Model-Based Framework for Designing Multi-Functional Proteins, Presented by Margaret L., GensaicC037: Functional Enzyme Discovery and Machine Learning Guided Enzyme Optimization for Biocatalysts, Presented by Joseph F. and Shurong H., Ginkgo BioworksC038: Comparative Analysis of N-1 Perfusion Strategies for Enhanced Protein Expression and Cost Efficiency in Biopharmaceutical Manufacturing, Presented by Sarah L., Hangzhou HealSun Biopharm Co., Ltd.C039: High Endothelial Venule-Targeting Drug Delivery in Metastatic Cancers, Presented by Sungwook J., Harvard Medical School<div>C040: Evaluation of a Bispecific Antibody Platform Using a 15 x 15 Matrix of Clinical Stage Antibodies, Presented by Jonathan D., Creative Antibodies</div><div> </div>C041: From Screening to Large Scale Purification: Adaptability of MagStrep® Strep-Tactin®XT Beads, Presented by Fabian M., IBA Lifesciences C042: The Cell Division Activator Protein of Salmonella typhi (StCAP) is a Key Pathogenic Inducer and Can Be Targeted with Selective Therapeutic Molecules, Presented by Bishwajit K., Indian Institute of Technology, DelhiC043: Engineering an Improved Inhibitor of 53BP1 to Enhance HDR Efficiency, Presented by Christopher V., Integrated DNA Technologies, Inc.C044: Small and Mighty – VHH ‘Bolt-Ons’ to Expand Therapeutic Functionality, Presented by Anna B., Isogenica Ltd.C045: Tailored AAV Solutions: ELISA Kits and Customized Variant Kit Development, Presented by Tingxu C., KactusC046: Accelerated Lead Cell Line Selection Through Early Process and CQA Screening with Cutting-Edge Technologies, Presented by Amelie M., KBI BiopharmaC047: A Novel Vector System for One-Step Generation of Diverse Vector Assemblies for Enhanced Product Titres of Multispecific Antibodies, Presented by Michael A., LonzaC048: TheraPRO® CHO Media System: Achieve High Productivity in CHOK1 GS-KO® Cell Lines with Our Advanced Formulated, Easy-to-Use Media and Feed Solution, Presented by Gaurav K., LonzaC049: Engineering Multi-Specific Antibodies for Prophylactic Treatment of Peanut Allergy, Presented by Rahel S., Mabylon AGC050: Tuning Heterodimeric Cytokine Receptor Signaling with Bispecific Antibody Agonists, Presented by Shaheen F., Merck & Co., Inc.C051: Analytical High-Throughput Automation: Advancing Vaccine Process Development, Presented by Carl H., Merck & Co., Inc.C052: Evaluation of a Growth-Based Rapid Microbiological Method for Detection of Aerobic and Anaerobic Bacteria in Recombinant Pharmaceuticals, Presented by Hokyung O., Ministry of Food and Drug Safety, KoreaC053: Controls of Drug-to-Antibody Ratio for Site-Specific and Non-Site-Specific Antibody-Drug-Conjugates, Presented by Lin-Lu T., Mycenax Biotech, Inc..C054: Accelerating the Development of Innovative Biologics in Canada, Presented by Melanie A., National Research Council CanadaC055: Noncanonical Intradomain Disulfide Linkages in Immunoglobulin Variable Domains: Implications in Efficacy Engineering of Antibody Therapeutics, Presented by Jamshid T., National Research Council CanadaC056: Directed and Efficient Therapeutic Cytokine Engineering Powered by AI and High Throughput Experimentation, Presented by Yang X., neoX Biotech, Inc.C057: Identifying the Determinants of Cell-Penetrant Miniproteins, Presented by Claire P., Northwestern UniversityC058: Enhancing Solubility of Protein Targets: Innovations in Expression Strategies Using eProtein Discovery™, Presented by Chava A., NucleraC059: DNA to Assay-Ready Proteins in 48 Hours: Rapid Protein Expression and Purification on the eProtein Discovery™ System and Binding Confirmation on Biacore™ SPR System, Presented by Yvonne T., NucleraC060: OmniChicken Derived Antibodies to a Member of the TNF Receptor Superfamily, Presented by Darlene P., OmniAb, Inc.C061: Cloud Enabled NGS-Based Antibody Discovery and 3D Antibody Structural Modeling, Presented by Suhani N., OpenEye Cadence Molecular SciencesC062: Performing Protein Expression, Purification, and Quantification on a Robotic Liquid Handling Platform, Presented by Boren L., Opentrons LabworksC063: High Throughput Hydrophobicity and Polyreactivity Assays for 6His-Tagged Proteins, Presented by Aris P., PAIA Biotech GmbHC064: Investigating the Excipient Effect In Vitro for Subcutaneous Pre-Clinical Formulations, Presented by Imogen A., Pion, Inc.C065: OpenCRISPR: Language Models Generate Novel Genome Editors from Scratch, Presented by Jeffrey R., Profluent BioC066: A Powerful Capillary Electrophoresis Platform for the Characterization of Viral Capsid Proteins of Vectors Used in Cell and Gene Therapies, Presented by Yasef K., ProteinSimple, a Bio-Techne brandC067: Overcoming Obstacles in Antibody Discovery: Investigating the Power of De Novo Polyclonal Sequencing, Presented by Jennifer C., Rapid NovorC068: Affinity Enrichment to Support Evaluation of Impactful Post-Translational Modifications on Therapeutic Monoclonal Antibodies, Presented by Jethro P., Regeneron PharmaceuticalsC069: Longitudinal Deep Multi-Omics Profiling in a CLN3Δex7/8 Minipig Model Reveals Novel Biomarker Signatures for Batten Disease, Presented by Hannah L., Sanford ResearchC070: Machine Learning Guided Identification of Novel Antibody Sequences with Defined Specificity, Presented by Ankit M., SanofiC071: Analytical Challenges for Developability Assessment of Multispecific Antibodies, Presented by Megan S., SanofiC072: Diagnostic Potential of BCR Repertoire NGS Analysis and Stereotypic BCR Clonotype Proved in Mouse B Cell Lymphoma Model, Presented by Soyeon J., Seoul National UniversityC073: Fully Human DLL3/CD3 TCEs with Excellent Killing Potency Against Small Cell Lung Cancer (SCLC) Cells, Presented by Jinghua G., Shanghai AceMab Biotechnology Ltd.C074: SPOC Biosensor Chips as a Novel Tool for Evaluating AI-Designed Antibody-Based Therapeutics’ Specificity Against Thousands of Targets Simultaneously, Presented by Bharath T., SPOC ProteomicsC075: STRO-004: A Precisely Designed Tissue Factor Targeted ADC for Broadened Efficacy and Safety, Presented by Grace L., Sutro BiopharmaC076: Machine Learning-Based Engineering of Reagent Enzymes Improves Nucleic Acid Detection: Application to Infectious Disease and Cancer Diagnostics, Presented by Thomas S., Tamarack Bioscience, Inc.C077: Targeted In Silico Design of Functional Enzyme Inhibitors, Presented by Darian W., Technical University of DenmarkC078: AI-Driven Screening of Blocking Antibodies Using tFold Structural Modeling, Presented by Biaobin J., TencentC079: Leveraging Cryo-Electron Microscopy for Innovative Vaccine Development, Presented by Tilak G., Thermo Fisher ScientificC080: Accelerating Discovery and Rational Engineering of Antibody Modalities Using Cryo-EM, Presented by Anass J., Thermo Fisher ScientificC081: Improving Intracellular Delivery of an Antibody-Drug Conjugate Targeting Carcinoembryonic Antigen Increases Efficacy at Clinically Relevant Doses In-Vivo, Presented by Baron R., University of MichiganC082: Building the Protein-Drug Revolution, Presented by Sneha V., University of MinnesotaC083: High Throughput Cysteinylation Screening at mAb Subunit Level Using LC-MS Monitoring Workflow, Presented by Guillaume B., Waters CorporationC084: Simple and Automatable Sample Preparation for Tryptic Peptide Mapping with the PeptideWorks Kit, Presented by Erin M., Waters CorporationC085: WuXi XDC’s Development Platforms Deliver Consistent and Scalable Conjugation Processes, Presented by Stuart W., WuXi BiologicsC086: From Sequence to Binding Clones, a Novel Computational Platform for Nanobody Discovery, Presented by Hao C., Yurogen Biosystems LLCC087: Development of Rabbit Anti-Mertansine (DM1) Monoclonal Antibodies, Presented by Ke Z, Yurogen Biosystems LLCC088: Development of CD40 and HER2 Bispecific Antibodies for Enhanced Efficacy Against HER2-Positive Tumors, Presented by Yang L., Yurogen Biosystems LLCC089: Cell-Free Expression of Antibodies from Veterinary Species, Presented by Erika O., ZoetisC090: Characterization of Livestock IgG Repertoire, Presented by Prajna S., ZoetisC091: TriTCE Co-Stim: A Next Generation Trispecific T Cell Engager Platform with Integrated CD28 Costimulation, Engineered to Improve T Cell Function and Antitumor Responses in Hard-to-Treat Cancers, Presented by Prajwal R. and Gursev A., Zymeworks, Inc.C092: Harnessing Display Technologies to Obtain Large Datasets for Machine Learning Training and Enhance Diagnostic Tools, Presented by Esen S., Los Alamos National LaboratoryC093: Genovac OptiAb™ Powered by ENPICOM- A Deep Learning Tool and Service for Next Generation Antibody Humanization, Presented by Matt W., Genovac Antibody Discovery<div>C094: Supporting CAR-T Cell Therapy Development from Discovery to IND-Filing, Presented by Brad G., Charles River Laboratories</div><div>C095: Bispecific Antibody Discovery Platform for IND Enabling Studies, Presented by Brad G., Charles River LaboratoriesC096: Cancerlysins™: Novel Bispecific Antibodies for Non-Toxic Targeted Tumor Eradication, Presented by Victor G., ImmuVia LLC</div>   <div> </div></div> </div></div> </div> <div class="col-sm-3"> <div id="Contentplaceholder1_T846F6E09001_Col01" class="sf_colsIn pad-lr" data-sf-element="Column 2" data-placeholder-label="Column 2"><div class='sfContentBlock'> <hr class="hidden-sm hidden-md hidden-lg" /><div class="social-icons"><a target="_blank" href="/docs/librariesprovider30/ics/25/pegs.ics?sfvrsn=2796fd80_1&download=true" title="Outlook"><img src="/images/default-source/social/calendar-gray.png?sfvrsn=91696e36_6" title="Outlook" alt="Outlook" class="social-icon" /></a> <a href="https://www.youtube.com/watch?v=z-nuXyv7Xr4" target="_blank" title="YouTube"><img src="/images/default-source/social/youtube-gray.png?sfvrsn=6bad7b8f_4" title="YouTube" alt="YouTube" class="social-icon" /></a> <a href="https://www.facebook.com/PEGSummit" target="_blank" title="Facebook"><img src="/images/default-source/social/facebook-gray.png?sfvrsn=35d4a48c_4" title="Facebook" alt="Facebook" class="social-icon" /></a> <a href="https://www.linkedin.com/groups/1830195/" target="_blank" title="LinkedIn"><img src="/images/default-source/social/linkedin-gray.png?sfvrsn=ed70471e_4" title="LinkedIn" alt="LinkedIn" class="social-icon" /></a> <a href="https://twitter.com/PEGSboston" target="_blank" title="Twitter"><img src="/images/default-source/social/twitter-gray.png?sfvrsn=bac909e7_7" title="Twitter" alt="Twitter" class="social-icon" /></a> <a href="https://www.healthtech.com/thechain" target="_blank" title="The Chain Podcast"><img src="/images/default-source/social/podcast-gray.png?sfvrsn=1ac8df66_1" title="The Chain Podcast" alt="Twitter" class="social-icon" /></a> </div><div class="sidebar-hashtag">#PEGSummit </div><hr /> </div><div class='sfContentBlock'><div><a href="https://register.cambridgeinnovationinstitute.com/reg/PEG"><img src="/images/librariesprovider30/sidebar/25/cta-register.png?sfvrsn=fa28426a_2" alt="Register Now" class="imageResize" /></a> </div><div class="sidebar-item"><a href="/speaker-proposal"><img src="/images/librariesprovider30/sidebar/25/cta-speaker.png?sfvrsn=dc498d46_1" class="imageResize" alt="Submit a Proposal" /></a> </div><div class="sidebar-item"><a href="/2024-brochure-download-form"><img src="/images/librariesprovider30/sidebar/25/download-brochure.png?sfvrsn=f6c6ad62_1" class="imageResize" alt="Download Brochure" /></a> </div><div class="sidebar-item"><a href="/docs/librariesprovider30/agenda-2019/25/peg25-cag.pdf?sfvrsn=9eb5dd98_2" target="_blank"><img src="/images/librariesprovider30/sidebar/25/cag.png?sfvrsn=3e256996_2" class="imageResize" alt="Download Conference at a Glance" /></a></div><div class="sidebar-item"><a href="/media-gallery"><img src="/images/librariesprovider30/sidebar/25/media-gallery.png?sfvrsn=c8b2f7dc_1" class="imageResize" alt="Media Gallery" /></a> </div><div class="sidebar-item"><a href="/posters"><img src="/images/librariesprovider30/sidebar/25/poster.png?sfvrsn=d9173fe4_1" class="imageResize" alt="Present a Poster" /></a> </div> </div> <div > <div class="sf-Long-text" ><hr /><h5 class="sidebar-nav-blue flush-top">2025 PROGRAMS</h5>View By:<div class="row"><div class="col-md-6"><div class="Tab1Btn active"><a id="Tab1Link" data-sf-ec-immutable="">      Topic      </a> </div></div> <div class="col-md-6"><div class="Tab2Btn"><a id="Tab2Link" data-sf-ec-immutable="">      Date      </a> </div></div></div><div class="Tab1 Tab-Content"><div class="toggle"><img src="/images/librariesprovider30/home/25/stream1-engineering.png?sfvrsn=9a47758_1" alt="Engineering" class="imageResize" /></div><div class="collapse inner-collapse-track"><ul class="terciary-text"><li><a href="/display-of-biologics" data-sf-ec-immutable="">Display of Biologics </a></li><li><a href="/engineering-antibodies" data-sf-ec-immutable="">Engineering Antibodies </a></li><li><a href="/machine-learning-for-protein-engineering" data-sf-ec-immutable="">Machine Learning for Protein Engineering </a></li></ul></div><div class="toggle"><img src="/images/librariesprovider30/home/25/stream2-oncology.png?sfvrsn=c28f944_1" class="imageResize" alt="Oncology" /></div><div class="collapse inner-collapse-track"><ul class="terciary-text"><li><a href="/cancer-antibodies" data-sf-ec-immutable="">Antibodies for Cancer Therapy </a></li><li><a href="/targets-for-oncology" data-sf-ec-immutable="">Emerging Targets for Oncology & Beyond </a></li><li><a href="/antibody-drug-conjugates" data-sf-ec-immutable="">Driving Clinical Success in Antibody-Drug Conjugates </a></li></ul></div><div class="toggle"><img src="/images/librariesprovider30/home/25/stream3-multispecifics.png?sfvrsn=da158542_1" class="imageResize" alt="Bispecific Antibodies" /></div><div class="collapse inner-collapse-track"><ul class="terciary-text"><li><a href="/training-seminars" data-sf-ec-immutable="">TS: Intro to Multispecific Antibodies </a></li><li><a href="/multispecific-antibodies" data-sf-ec-immutable="">Advancing Multispecific Antibodies </a></li><li><a href="/bispecific-antibodies" data-sf-ec-immutable="">Engineering Bispecific and Multifunctional Antibodies </a></li></ul></div><div class="toggle"><img src="/images/librariesprovider30/home/25/stream4-immunotherapy.png?sfvrsn=3e682bbd_1" class="imageResize" alt="Immunotherpary" /></div><div class="collapse inner-collapse-track"><ul class="terciary-text"><li><a href="/immunotherapy" data-sf-ec-immutable="">Advances in Immunotherapy </a></li><li><a href="/cell-based-immunotherapies" data-sf-ec-immutable="">Engineering Cell Therapies </a></li><li><a href="/next-generation-immunotherapies" data-sf-ec-immutable="">Next-Generation Immunotherapies </a></li></ul></div><div class="toggle"><img src="/images/librariesprovider30/home/25/stream5-expression.png?sfvrsn=54d3e7e1_1" class="imageResize" alt="Expression" /></div><div class="collapse inner-collapse-track"><ul class="terciary-text"><li><a href="/difficult-to-express-proteins" data-sf-ec-immutable="">Difficult-to-Express Proteins </a></li><li><a href="/protein-expression" data-sf-ec-immutable="">Optimizing Protein Expression </a></li><li><a href="/protein-production" data-sf-ec-immutable="">Maximizing Protein Production Workflows </a></li></ul></div><div class="toggle"><img src="/images/librariesprovider30/home/25/stream6-analytical.png?sfvrsn=1b76226c_1" class="imageResize" alt="Analytical" /></div><div class="collapse inner-collapse-track"><ul class="terciary-text"><li><a href="/machine-learning-and-digital-integration-in-biotherapeutic-analytics" data-sf-ec-immutable="">ML and Digital Integration in Biotherapeutic Analytics </a></li><li><a href="/biophysical-methods" data-sf-ec-immutable="">Biophysical Methods </a></li><li><a href="/biotherapeutics-characterization" data-sf-ec-immutable="">Characterization for Novel Biotherapeutics </a></li></ul></div><div class="toggle"><img src="/images/librariesprovider30/home/25/stream7-immunigenicity.png?sfvrsn=bbcfc0e5_1" class="imageResize" alt="Immunogenicity" /></div><div class="collapse inner-collapse-track"><ul class="terciary-text"><li><a href="/training-seminars" data-sf-ec-immutable="">TS: Intro to Immunogenicity </a></li><li><a href="/immunogenicity" data-sf-ec-immutable="">Predicting Immunogenicity with AI/ML Tools </a></li><li><a href="/training-seminars" data-sf-ec-immutable="">TS: Introduction to Bioassay Development and Analysis</a></li></ul></div><div class="toggle"><img src="/images/librariesprovider30/home/25/stream8-therapies.png?sfvrsn=b2bb9434_2" class="imageResize" alt="Emerging Modalities" /></div><div class="collapse inner-collapse-track"><ul class="terciary-text"><li><a href="/biologics-for-immunology-indications" data-sf-ec-immutable="">Biologics for Immunology Indications </a></li><li><a href="/radiopharmaceutical-therapies" data-sf-ec-immutable="">Radiopharmaceutical Therapies </a></li><li><a href="/next-generation-immunotherapies" data-sf-ec-immutable="">Next-Generation Immunotherapies </a></li></ul></div><div class="toggle"><img src="/images/librariesprovider30/home/25/stream10-ml.png?sfvrsn=20fd4965_1" class="imageResize" alt="Machine Learning Stream" /></div><div class="collapse inner-collapse-track"><ul class="terciary-text"><li><a href="/machine-learning-and-digital-integration-in-biotherapeutic-analytics" data-sf-ec-immutable="">ML and Digital Integration in Biotherapeutic Analytics </a></li><li><a href="/immunogenicity" data-sf-ec-immutable="">Predicting Immunogenicity with AI/ML Tools </a></li><li><a href="/machine-learning-for-protein-engineering" data-sf-ec-immutable="">Machine Learning for Protein Engineering </a></li></ul></div></div><div class="Tab2 Tab-Content"><hr class="flush-top" />May 12-13<a href="/display-of-biologics" data-sf-ec-immutable="">Display of Biologics</a><a href="/cancer-antibodies" data-sf-ec-immutable="">Antibodies for Cancer Therapy</a><a href="/immunotherapy" data-sf-ec-immutable="">Advances in Immunotherapy</a><a href="/difficult-to-express-proteins" data-sf-ec-immutable="">Difficult-to-Express Proteins</a><a href="/machine-learning-and-digital-integration-in-biotherapeutic-analytics" data-sf-ec-immutable="">ML and Digital Integration in Biotherapeutic Analytics</a><a href="/biologics-for-immunology-indications" data-sf-ec-immutable="">Biologics for Immunology Indications</a>May 13-14<a href="/engineering-antibodies" data-sf-ec-immutable="">Engineering Antibodies</a><a href="/multispecific-antibodies" data-sf-ec-immutable="">Advancing Multispecific Antibodies </a><a href="/targets-for-oncology" data-sf-ec-immutable="">Emerging Targets for Oncology and Beyond</a><a href="/cell-based-immunotherapies " data-sf-ec-immutable="">Engineering Cell Therapies</a><a href="/protein-expression" data-sf-ec-immutable="">Optimizing Protein Expression</a><a href="/biophysical-methods" data-sf-ec-immutable="">Biophysical Methods</a><a href="/immunogenicity" data-sf-ec-immutable="">Predicting Immunogenicity with AI/ML Tools</a><a href="/radiopharmaceutical-therapies" data-sf-ec-immutable="">Radiopharmaceutical Therapies</a>May 15-16<a href="/machine-learning-for-protein-engineering" data-sf-ec-immutable="">Machine Learning for Protein Engineering</a><a href="/antibody-drug-conjugates" data-sf-ec-immutable="">Driving Clinical Success in Antibody-Drug Conjugates</a><a href="/bispecific-antibodies" data-sf-ec-immutable="">Engineering Bispecific and Multifunctional Antibodies</a><a href="/next-generation-immunotherapies" data-sf-ec-immutable="">Next-Generation Immunotherapies</a><a href="/protein-production" data-sf-ec-immutable="">Maximizing Protein Production Workflows</a><a href="/biotherapeutics-characterization" data-sf-ec-immutable="">Characterization for Novel Biotherapeutics</a><hr /></div></div> </div> <div > <div class="sf-Long-text" ><div style="color:#000000;background-color:#dcedff;padding:5px;text-align:center;font-size:18px;">Premier Sponsors</div> <div class="sponsors-group"><a href="https://www.ablexis.com/" target="_blank" data-sf-ec-immutable=""><img src="/images/default-source/sponsor-logos/a-g/ablexis_alivamab_new.jpg?sfvrsn=1de597f8_1" alt="" sf-size="4596" /></a><a href="https://fjb.pt/" title="Fairjourney" target="_blank" data-sf-ec-immutable=""><img src="/images/default-source/sponsor-logos/a-g/fairjourneybiologics.jpg?sfvrsn=c59b98e_2" alt="FairJourneyBiologics" sf-size="4426" /></a> <a href="https://www.genscript.com/" title="Genscript" target="_blank" data-sf-ec-immutable=""><img src="/images/default-source/sponsor-logos/a-g/genscript-cro.jpg?sfvrsn=2027e88c_4" alt="GenScript-CRO" sf-size="3910" /></a> <img src="/images/default-source/sponsor-logos/h-m/integral-molecular_new.jpg?sfvrsn=a902483c_2" title="Integral-Molecular_NEW" data-displaymode="Original" alt="Integral-Molecular_NEW" />  <a href="https://www.omniab.com/" title="OmniAb" target="_blank" data-sf-ec-immutable=""><img src="/images/default-source/sponsor-logos/n-s/omniabe929d389-e67c-480d-be66-975d1b4351da.jpg?sfvrsn=60471a65_1" alt="OmniAb" sf-size="16167" /></a><a target="_blank" href="https://www.unchainedlabs.com/"><img src="/images/default-source/sponsor-logos/t-z/unchainedlabs.jpg?sfvrsn=a7bc746b_2" title="UnchainedLabs" data-displaymode="Original" alt="UnchainedLabs" /></a> </div></div> </div></div> </div> </div> </div> </div> </div> <footer> <div > <div class="sf-Long-text" ><div class="footer"><div class="container"><div class="row"><div class="col-sm-3 col-xs-12"><div class="footer-small"><div class="footer-small-inner"><img alt="CHI | Cambridge HealthTech Institute" class="CII-footer" src="/UploadedImages/CHI-logo.png" data-sf-ec-immutable="" /> 250 First Avenue, Suite 300 Needham, MA 02494 P: 781.972.5400 F: 781.972.5425 E: <a href="mailto:chi@healthtech.com?cdtConferenceId=404272006.1663694140&cdtRollupId=404272006.1663694140" data-sf-ec-immutable="">chi@healthtech.com</a> <div class="row"><div class="col-sm-12 footer-social"><a href="https://twitter.com/CHI_Healthtech" data-sf-ec-immutable=""><img src="/images/default-source/social/twitter-gray.png?sfvrsn=bac909e7_7" alt="" class="footer-social-icons" /></a> <a href="https://www.linkedin.com/company/cambridge-healthtech-institute" data-sf-ec-immutable=""><img src="/images/default-source/social/linkedin-gray.png?sfvrsn=ed70471e_4" class="footer-social-icons" alt="" /></a> <a href="https://www.facebook.com/HealthtechConferences" data-sf-ec-immutable=""><img src="/images/default-source/social/facebook-gray.png?sfvrsn=35d4a48c_4" class="footer-social-icons" alt="" /></a> </div></div></div></div></div><div class="col-sm-4 footer-border hidden-xs"><div class="row"><div class="col-sm-12">Life Science Portals</div><div class="col-sm-6"><a href="http://biologicaltherapeutics.cambridgeinnovationinstitute.com/home">Biological Therapeutic Products</a><a href="http://biomarkers.cambridgeinnovationinstitute.com/home">Biomarkers & Diagnostics</a><a href="http://biopharmastrategy.cambridgeinnovationinstitute.com/home">Biopharma Strategy</a><a href="https://bioprocessing.cambridgeinnovationinstitute.com/home">Bioprocess & Manufacturing</a><a href="http://chemistry.cambridgeinnovationinstitute.com/home">Chemistry</a><a href="http://clinicaltrials.cambridgeinnovationinstitute.com/home">Clinical Trials & Translational Medicine</a><a href="http://druganddevice.cambridgeinnovationinstitute.com/home">Drug & Device Safety</a></div><div class="col-sm-6"><a href="http://drugdevelopment.cambridgeinnovationinstitute.com/home">Drug Discovery & Development</a><a href="http://drugtargets.cambridgeinnovationinstitute.com/home">Drug Targets</a><a href="http://healthcare.cambridgeinnovationinstitute.com/home">Healthcare</a><a href="http://it.cambridgeinnovationinstitute.com/home">IT, AI, ML & Informatics</a><a href="http://techtools.cambridgeinnovationinstitute.com/home">Technology & Tools For Life Science</a><a href="http://therapeutics.cambridgeinnovationinstitute.com/home">Therapeutic Indications</a><a href="https://www.cambridgeinnovationinstitute.com/vip-series" data-sf-ec-immutable="">Venture, Innovation & Partnering</a></div></div></div><div class="col-sm-3 footer-border hidden-xs">CHI Divisions<a href="https://www.healthtech.com/?cdtConferenceId=404272006.1663694140&cdtRollupId=404272006.1663694140" data-sf-ec-immutable="">Conferences</a><a href="https://www.insightpharmareports.com/" data-sf-ec-immutable="">Reports & Market Research</a><a href="https://www.barnettinternational.com/" data-sf-ec-immutable="">Barnett Educational Services</a><a href="https://www.healthtech.com/publishing" data-sf-ec-immutable="">News & Advertising</a><a href="https://proservices.healthtech.com/?cdtConferenceId=404272006.1663694140&cdtRollupId=404272006.1663694140" data-sf-ec-immutable="">Professional Services</a></div><div class="col-sm-2 footer-border hidden-xs">Corporate Information<a href="https://www.cambridgeinnovationinstitute.com/" data-sf-ec-immutable="">Cambridge Innovation Institute</a><a href="https://www.cambridgeinnovationinstitute.com/Executive-Team/" data-sf-ec-immutable="">Executive Team</a><a href="https://www.cambridgeinnovationinstitute.com/Testimonials/" data-sf-ec-immutable="">Testimonials</a><a href="https://www.cambridgeinnovationinstitute.com/mailing-list.html" data-sf-ec-immutable="">Mailing List</a><a href="https://www.cambridgeinnovationinstitute.com/Careers/" title="Careers" data-sf-ec-immutable="">Careers</a><hr /><a href="https://www.cambridgeinnovationinstitute.com/request-information" data-sf-ec-immutable="">Request Information</a><a href="https://www.cambridgeinnovationinstitute.com/Privacy-Policy/" data-sf-ec-immutable="">Privacy Policy</a></div></div></div></div></div> </div> </footer> <script type="text/javascript"> //<![CDATA[ window.__TsmHiddenField = $get('ctl04_TSM');;(function() { function loadHandler() { var hf = $get('ctl05_TSSM'); if (!hf._RSSM_init) { hf._RSSM_init = true; hf.value = ''; } hf.value += ';Telerik.Sitefinity.Resources, Version=14.2.7900.0, Culture=neutral, PublicKeyToken=b28c218413bdf563:en:ec7772cc-ee32-478e-8437-4242283bb12f:7a90d6a'; Sys.Application.remove_load(loadHandler); }; Sys.Application.add_load(loadHandler); })();//]]> </script> </form><script type="application/json" id="PersonalizationTracker"> {"IsPagePersonalizationTarget":false,"IsUrlPersonalizationTarget":false,"PageId":"3947ca16-4cca-46e2-addf-4b4dd64ddb72"} </script><script type="text/javascript" src="/WebResource.axd?d=Oiw5o8i74rDb2VpVaCaMSouKRnJ2rn_cgRr8eXgFzWmU6yVv8fmvjGNlDReMboLSikSmK5y_KsDt9j-18b7ZqBNiz0-92AjY43-6qMcq4O__3MjW1Pd6kS68TTYuxCxnF4HnqcusO3ivgfHZzR9usujs8YAzvYku29ledrs3mezPir5ikBP0Pxh4nDmiJEk2WgW0YVPdsdMlu69MVd6jI94nvC3-40pMaRxtm9HTV2I1&t=637922505260000000"> </script><script type="text/javascript" src="/js/toggle-V2.js"></script><script type="text/javascript" src="/bower_components/js-url/url.min.js"></script><script type="text/javascript" src="/js/TrackClicks.js"></script><script type="text/javascript" src="/js/CrossDomainClient.js"></script></body> </html>